Citation Impact
2 from Science/Nature 76 standout
Citing Papers
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Persistent physical symptoms: definition, genesis, and management
2024 Standout
Works of Ryan DeMasi being referenced
Patient-reported outcomes for tofacitinib with and without methotrexate, or adalimumab with methotrexate, in rheumatoid arthritis: a phase IIIB/IV trial
2019
THU0185 Tofacitinib, An Oral JAK Inhibitor, in The Treatment of Rheumatoid Arthritis: Safety and Clinical and Radiographic Efficacy in Open-Label, Long-Term Extension Studies over 7 Years
2016
Author Peers
| Author | Rheumatology | Hematology | Genetics | Oncology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| Ryan DeMasi | 723 | 376 | 162 | 229 | 30 | 1.0k | |
| Danhui Weng | 22 | 11 | 55 | 480 | 41 | 1.5k | |
| Joke Devoldere | 4 | 4 | 12 | 12 | 524 | ||
| Gene L. LaBerge | 11 | 241 | |||||
| Takashi Dejima | 6 | 6 | 3 | 108 | 25 | 578 | |
| Lisa Küpper | 5 | 1.3k |
All Works
Loading papers...